Gravity sedimentation of leukocytes is partially independent from erythrocyte sedimentation.
Leukocyte function tests are suitable for monitoring the severity of chronic inflammatory and acute infectious diseases. The tests usually require time consuming leukocyte separation techniques while the original character of leukocytes can substantially alter. In contrast, we noted that gravity sedimentation properties of leukocytes is simple to measure and it also reflects non-specific inflammatory reactions of leukocytes. Our novel test is named leukocyte antisedimentation rate (LAR) which is measured by leukocyte counting in the upper (U) and lower (L) half of the sedimentation blood column after one-hour gravity sedimentation of the whole blood. The formula LAR=100.(U-L)/(U+L) is used to calculate the percentage of leukocytes crosses the middle line of sedimentation blood column upward during one-hour sedimentation (normal range<15%, inter-assay coefficient of variation<5%). In this study we found that in vitro pre-treatment of septic patients' blood samples with protamine, lidocaine and prednisolone decreased leukocyte antisedimentation rate in a concentration dependent manner without effecting erythrocyte sedimentation rate. Leukocyte adherence was measured by the retention rate of leukocytes in a nylon fibre column. There was a significant positive correlation between leukocyte antisedimentation rate and leukocyte adherence (p<0.01), hematocrit (p<0.05), erythrocyte sedimentation rate (p<0.05) when blood samples of 35 healthy individuals were analysed. We concluded that leukocyte antisedimentation rate in septic patients is significantly elevated comparing to healthy controls and as a bedside test it can reflect leukocyte involvement in infections. In vitro protamine, lidocaine and prednisolone pre-treatment of septic patients' blood samples indicates that leukocyte antisedimentation process is partially independent from the ongoing erythrocyte sedimentation.
Bogar
L L
LL
Department of Anaesthesiology and Critical Care, University of Pecs, Pecs, Hungary. bogar@clinics.pote.hu
Tarsoly
P P
PP
D000328:Adult; D000779:Anesthetics, Local / Q000494:pharmacology; D000893:Anti-Inflammatory Agents / Q000494:pharmacology; D001799:Blood Sedimentation; D002448:Cell Adhesion / Q000187:drug effects; D002469:Cell Separation / Q000379:methods; D005260:Female; D006494:Heparin Antagonists / Q000494:pharmacology; D006801:Humans; D007962:Leukocytes / Q000187:drug effects / Q000502:physiology*; D008012:Lidocaine / Q000494:pharmacology; D008297:Male; D008875:Middle Aged; D011239:Prednisolone / Q000494:pharmacology; D011479:Protamines / Q000494:pharmacology
D000779:Anesthetics, Local; D000893:Anti-Inflammatory Agents; D006494:Heparin Antagonists; D011479:Protamines; D008012:Lidocaine; D011239:Prednisolone